Stock News

At Bancorp Has Decreased Its Position in Open Text (OTEX) by $437,600; As Abbott Labs (ABT) Market Valuation Declined, Clifford Swan Investment Counsel Lowered by $322,982 Its Holding

At Bancorp decreased its stake in Open Text Corp (OTEX) by 16.88% based on its latest 2017Q3 regulatory filing with the SEC. At Bancorp sold 13,675 shares as the company’s stock declined 3.85% while stock markets rallied. The institutional investor held 67,355 shares of the edp services company at the end of 2017Q3, valued at $2.18M, down from 81,030 at the end of the previous reported quarter. At Bancorp who had been investing in Open Text Corp for a number of months, seems to be less bullish one the $8.92B market cap company. The stock decreased 0.62% or $0.21 during the last trading session, reaching $33.6. About 674,170 shares traded or 13.31% up from the average. Open Text Corporation (NASDAQ:OTEX) has risen 15.94% since January 17, 2017 and is uptrending. It has underperformed by 0.76% the S&P500.

Clifford Swan Investment Counsel Llc decreased its stake in Abbott Labs (ABT) by 1.85% based on its latest 2017Q3 regulatory filing with the SEC. Clifford Swan Investment Counsel Llc sold 6,094 shares as the company’s stock declined 3.42% while stock markets rallied. The institutional investor held 323,529 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $17.26 million, down from 329,623 at the end of the previous reported quarter. Clifford Swan Investment Counsel Llc who had been investing in Abbott Labs for a number of months, seems to be less bullish one the $101.72B market cap company. The stock decreased 0.68% or $0.4 during the last trading session, reaching $58.44. About 7.18M shares traded or 20.89% up from the average. Abbott Laboratories (NYSE:ABT) has risen 15.90% since January 17, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

Clifford Swan Investment Counsel Llc, which manages about $2.29B and $1.65B US Long portfolio, upped its stake in Stericycle Inc. (NASDAQ:SRCL) by 28,508 shares to 179,855 shares, valued at $12.88 million in 2017Q3, according to the filing. It also increased its holding in Bristol (NYSE:BMY) by 14,345 shares in the quarter, for a total of 351,019 shares, and has risen its stake in Discovery Communications Ser. (NASDAQ:DISCK).

Since August 1, 2017, it had 0 insider buys, and 6 sales for $22.86 million activity. On Tuesday, August 1 the insider Bracken Sharon J sold $98,323. $2.74M worth of stock was sold by Contreras Jaime on Friday, September 22. $9.73 million worth of stock was sold by Fussell Stephen R on Wednesday, August 16.

Analysts await Abbott Laboratories (NYSE:ABT) to report earnings on January, 24 before the open. They expect $0.73 earnings per share, up 12.31% or $0.08 from last year’s $0.65 per share. ABT’s profit will be $1.27B for 20.01 P/E if the $0.73 EPS becomes a reality. After $0.66 actual earnings per share reported by Abbott Laboratories for the previous quarter, Wall Street now forecasts 10.61% EPS growth.

Investors sentiment decreased to 0.87 in Q3 2017. Its down 0.01, from 0.88 in 2017Q2. It dropped, as 47 investors sold ABT shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported. Massachusetts-based Northeast Management has invested 0.64% in Abbott Laboratories (NYSE:ABT). Security Retail Bank Of Sioux City Iowa Ia owns 70 shares. 266,998 were reported by Cullinan. The New York-based Goldman Sachs Group has invested 0.23% in Abbott Laboratories (NYSE:ABT). Engineers Gate Manager Lp holds 0.11% or 24,886 shares. Pinnacle Financial holds 0.33% in Abbott Laboratories (NYSE:ABT) or 47,873 shares. 613,149 are owned by Huntington National Bank & Trust. Portland Limited Liability Co reported 0.55% of its portfolio in Abbott Laboratories (NYSE:ABT). Orrstown Fin holds 19,243 shares or 1.15% of its portfolio. Moreover, Farmers National Bank & Trust has 0.12% invested in Abbott Laboratories (NYSE:ABT). S&Co invested in 1.91% or 280,380 shares. Garrison Bradford And Associates, New York-based fund reported 5,400 shares. Provise Management Grp Inc Ltd stated it has 23,607 shares or 0.18% of all its holdings. Palo Cap stated it has 73,522 shares or 2.07% of all its holdings. Longer Invs Incorporated stated it has 42,135 shares.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories has $90 highest and $4 lowest target. $51.95’s average target is -11.11% below currents $58.44 stock price. Abbott Laboratories had 92 analyst reports since July 24, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Friday, October 6 by JP Morgan. The rating was maintained by Deutsche Bank on Saturday, August 29 with “Buy”. The stock has “Buy” rating by Stifel Nicolaus on Thursday, July 20. JP Morgan upgraded Abbott Laboratories (NYSE:ABT) on Tuesday, January 2 to “Overweight” rating. BMO Capital Markets upgraded Abbott Laboratories (NYSE:ABT) on Tuesday, December 12 to “Outperform” rating. The rating was maintained by Jefferies on Tuesday, September 5 with “Buy”. On Tuesday, June 14 the stock rating was maintained by Jefferies with “Buy”. The firm earned “Buy” rating on Wednesday, October 18 by Jefferies. Northland Capital downgraded the shares of ABT in report on Thursday, September 28 to “Hold” rating. The rating was maintained by Gabelli with “Buy” on Friday, July 21.

At Bancorp, which manages about $877.87 million US Long portfolio, upped its stake in Bank Of America Corporation (NYSE:BAC) by 28,185 shares to 51,284 shares, valued at $1.30 million in 2017Q3, according to the filing. It also increased its holding in Spdr Series Trust (JNK) by 35,666 shares in the quarter, for a total of 336,974 shares, and has risen its stake in Schwab Strategic Tr (SCHX).

Analysts await Open Text Corporation (NASDAQ:OTEX) to report earnings on February, 1. They expect $0.12 EPS, down 33.33% or $0.06 from last year’s $0.18 per share. OTEX’s profit will be $31.86 million for 70.00 P/E if the $0.12 EPS becomes a reality. After $0.14 actual EPS reported by Open Text Corporation for the previous quarter, Wall Street now forecasts -14.29% negative EPS growth.

Among 10 analysts covering OpenText Corporation (NASDAQ:OTEX), 8 have Buy rating, 1 Sell and 1 Hold. Therefore 80% are positive. OpenText Corporation has $76 highest and $31.5 lowest target. $46.55’s average target is 38.54% above currents $33.6 stock price. OpenText Corporation had 21 analyst reports since July 30, 2015 according to SRatingsIntel. The company was maintained on Monday, October 30 by RBC Capital Markets. The firm earned “Buy” rating on Wednesday, July 12 by RBC Capital Markets. The firm has “Buy” rating by BMO Capital Markets given on Thursday, August 3. On Tuesday, July 28 the stock rating was maintained by Barclays Capital with “Overweight”. On Thursday, February 16 the stock rating was initiated by Citigroup with “Neutral”. The firm has “Buy” rating by BMO Capital Markets given on Wednesday, November 1. Barclays Capital maintained Open Text Corporation (NASDAQ:OTEX) on Friday, August 4 with “Overweight” rating. The stock has “Outperform” rating by BMO Capital Markets on Tuesday, September 13. Raymond James maintained Open Text Corporation (NASDAQ:OTEX) rating on Wednesday, November 22. Raymond James has “Buy” rating and $40.0 target. The stock of Open Text Corporation (NASDAQ:OTEX) earned “Outperform” rating by RBC Capital Markets on Thursday, July 30.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *